Reagents News and Research

RSS

Huntington’s disease prevention breakthrough? An interview with Professor Lesley Jones

Huntington’s disease is an inherited disease which, whilst quite rare, is one of the more common inherited neurodegenerative diseases. About 1 in 6,000 people in the UK are at risk and what’s horrible about this disease is that if one of your parents has it, then you have a fifty-fifty chance of inheriting it.

2 Sep 2015

Researchers successfully use alcohols as reagents in alkylation reaction

Researchers at Princeton have developed a dual catalyst system that directly installs alkyl groups--fragments containing singly bonded carbon and hydrogen atoms that have extremely useful properties for drug discovery--onto compounds called heteroarenes. The new reaction uses simple and abundant alcohols and offers a milder and more widely applicable alternative to existing strategies.

28 Aug 2015

WHO provides emergency health access to internally displaced persons, host communities in Taiz and Hodeida governorates

In response to the growing humanitarian crisis in Tiaz and Hodeida governorates, and the rising number of civilian injuries in the southern governorates of Yemen, WHO is coordinating a rapid response to provide emergency health access to the injured, internally displaced persons and host communities.

25 Aug 2015

Mexican engineer designs new ring that can help diagnose sexually transmitted diseases

A ring with the ability to diagnose sexually transmitted diseases like syphilis, gonorrhea, chlamydia and trichomoniasis was designed by the Mexican Ernesto Rodríguez Leal.

24 Aug 2015

Normal coagulation tests used to check for side effect of internal bleeding may not be reliable

A recently-published study found that while internal bleeding may be uncommon as a result of taking blood thinners such as Xarelto (rivaroxaban) and Eliquis (apixaban), the normal coagulation tests physicians use to check for the side effect of bleeding may not be reliable.

24 Aug 2015

Researchers at Forsyth Institute enhance pipetting efficiency using VIAFLO Assist

INTEGRA reports on how researchers at the renowned Forsyth Institute (Cambridge, MA) are using a VIAFLO Assist to enhance the efficiency while maintaining the accuracy of pipetting protocols related to the discovery, measurement, and validation of new biomarkers of disease that can be found in saliva.

From INTEGRA Biosciences 18 Aug 2015

Instrumentation Laboratory announces European release of HemosIL Rivaroxaban Testing Solution

Instrumentation Laboratory today announced the commercialization of their HemosIL Rivaroxaban Testing Solution in Europe. The HemosIL Liquid Anti-Xa assay, when used in conjunction with HemosIL Rivaroxaban Calibrators and HemosIL Rivaroxaban controls offers an automated solution for measurement of rivaroxaban.

10 Aug 2015

SGI-DNA recognized by Frost & Sullivan for BioXp 3200 System

SGI-DNA, a Synthetic Genomics, Inc. company, was recently recognized by Frost & Sullivan for its groundbreaking innovation in genomic technologies for the BioXp 3200 System, an instrument with the capacity to simultaneously build 32 unique, double-stranded DNA fragments to study gene function, pathways, and whole genomes.

4 Aug 2015

Oxford Gene Technology expands portfolio of fluorescence in situ hybridisation probes

Oxford Gene Technology (OGT), The Molecular Genetics Company, is extending its portfolio of Cytocell® Pathology FISH probes with the addition of eight new probes. OGT offers the widest range of fluorescence in situ hybridisation (FISH) probes on the market, delivering a cost-effective and reliable solution for anyone engaged in FISH.

From Oxford Gene Technology 28 Jul 2015

EKF Diagnostics launches new clinical chemistry analyzer at AACC 2015

EKF, announces international launch of the Altair™ 240 clinical chemistry analyzer at the American Association for Clinical Chemistry’s.

From EKF Diagnostics 23 Jul 2015

Inova Diagnostics announces FDA clearance for QUANTA Flash assays, QUANTA Flash Beta-2GP1 Domain1

Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug Administration on key QUANTA Flash assays for use with Inova Diagnostics' BIO-FLASH chemiluminescent analyzer for autoimmune testing.

20 Jul 2015

Rubicon Genomics completes $2 million growth capital financing

Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing.

15 Jul 2015

Researchers develop sperm RNA diagnostic test to help determine best infertility treatment for couples

A Wayne State University School of Medicine professor, in collaboration with researchers at CReAte Fertility Center, University of Toronto, Harvard University and Georgia Reagents University, has developed the first diagnostic test for sperm RNA based on next-generation sequencing. For couples with unexplained infertility, the test may help determine the best infertility treatment for couples having difficulty conceiving.

12 Jul 2015

Domainex’s new integrated bioassay service platform accelerates progression of drug discovery projects

Domainex Ltd, a private drug discovery service company, today announces that it is launching an integrated bioassay service platform, BioassayBuilder.

2 Jul 2015

Ortho Clinical Diagnostics announces FDA approval of VITROS Chemistry Products HbA1c Reagent Kit for diagnosis of diabetes

Ortho Clinical Diagnostics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the VITROS Chemistry Products HbA1c Reagent Kit to be used on the VITROS 5600 Integrated System, VITROS 4600 Chemistry System, and the VITROS 5,1 FS Chemistry System. The test can be used for the quantitative determination of percent glycated hemoglobin A1c (DCCT/NGSP) and mmol/mol hemoglobin A1c (IFCC) in human whole blood.

From Ortho-Clinical Diagnostics, Inc. 22 Jun 2015

Sebia’s Capillarys 3 Tera automated electrophoresis solution receives CE mark

Sebia, the world leader in capillary electrophoresis, today announces that Capillarys 3 Tera now has the CE mark for HbA1c and serum protein testing, and immunotyping. The CE mark for these tests is the first step in bringing the Capillarys 3 suite to market.

12 Jun 2015

Synthetic Genomics, Gen9 sign strategic licensing agreement for Febit intellectual property estate

Synthetic Genomics, Inc., a synthetic biology company advancing and innovating genomic science and technologies for transformative products and solutions, and Gen9 Inc., a pioneer in synthetic biology and leader in the development of scalable technologies for synthesizing and assembling DNA, today announced a strategic licensing agreement to leverage their respective strengths in synthetic biology technology development and commercialization.

11 Jun 2015

Simple process for obtaining induced pluripotent stem cells without use of reagents

For their ability to differentiate into other cell types, the embryonic stem cells hold a large potential in the medical industry. Their use, however, poses ethical questions due to the fact that in order to obtain them, it is necessary to destroy the embryo. For this reason, medical researches use the so-called induced pluripotent stem cells (iPSC). In fact, it is possible to reprogram adult cells that can be obtained by simply drawing blood and making them "regress" to a similar state to that of embryonic stem cells.

10 Jun 2015

New study outlines framework for long-term improvements in life science research reproducibility rates

A new study published in Open Access journal PLOS Biology by the Global Biological Standards Institute (GBSI) and two leading economists estimates that, in the U.S. alone, approximately $28 billion per year is spent on preclinical research that is not reproducible.

10 Jun 2015

MIPT researchers develop ultrasensitive nanomechanical sensor to identify tumor markers

Two young researchers working at the MIPT Laboratory of Nanooptics and Plasmonics, Dmitry Fedyanin and Yury Stebunov, have developed an ultracompact highly sensitive nanomechanical sensor for analyzing the chemical composition of substances and detecting biological objects, such as viral disease markers, which appear when the immune system responds to incurable or hard-to-cure diseases, including HIV, hepatitis, herpes, and many others.

10 Jun 2015

Reagents News and Research

Huntington’s disease prevention breakthrough? An interview with Professor Lesley Jones

Researchers successfully use alcohols as reagents in alkylation reaction

WHO provides emergency health access to internally displaced persons, host communities in Taiz and Hodeida governorates

Mexican engineer designs new ring that can help diagnose sexually transmitted diseases

Normal coagulation tests used to check for side effect of internal bleeding may not be reliable

Researchers at Forsyth Institute enhance pipetting efficiency using VIAFLO Assist

Instrumentation Laboratory announces European release of HemosIL Rivaroxaban Testing Solution

SGI-DNA recognized by Frost & Sullivan for BioXp 3200 System

Oxford Gene Technology expands portfolio of fluorescence in situ hybridisation probes

EKF Diagnostics launches new clinical chemistry analyzer at AACC 2015

Inova Diagnostics announces FDA clearance for QUANTA Flash assays, QUANTA Flash Beta-2GP1 Domain1

Rubicon Genomics completes $2 million growth capital financing

Researchers develop sperm RNA diagnostic test to help determine best infertility treatment for couples

Domainex’s new integrated bioassay service platform accelerates progression of drug discovery projects

Ortho Clinical Diagnostics announces FDA approval of VITROS Chemistry Products HbA1c Reagent Kit for diagnosis of diabetes

Sebia’s Capillarys 3 Tera automated electrophoresis solution receives CE mark

Synthetic Genomics, Gen9 sign strategic licensing agreement for Febit intellectual property estate

Simple process for obtaining induced pluripotent stem cells without use of reagents

New study outlines framework for long-term improvements in life science research reproducibility rates

MIPT researchers develop ultrasensitive nanomechanical sensor to identify tumor markers

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News